Flucovag: efficacy and safety in patients with vulvovaginal candidiasis: a prospective, multicenter, open-label, randomized, comparative clinical study

• Principais autores: Flora R. Kutueva (Autor), Ruslan I. Glushakov (Autor), Natalia I. Tapilskaya (Autor), Alla E. Nikolaeva (Autor), Artem A. Poromov (Autor), Olga A. Pustotina (Autor)
• Formato: Livro
• Publicado em: IP Berlin A.V., 2023-04-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Design. A prospective, multicenter, open-label, randomized, comparative clinical study. Objective. To compare the efficacy and safety of Flucovag (sertaconazole) vaginal suppositories, 300 mg (OTCPharm JSC, Russia; manufactured by Altpharm LLC, Russia) and the brand-name drug Zalain (sertaconazole),...